Send feedback

A2M p.Val120=

c.360G>A · rs201901298 · VCV734227

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0636%, nfe)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 0.26GERP 1.7, phastCons 0.01
Overall
CADD4.901PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0636% European (non-Finnish) · 750/1,179,830 alleles
Filtering AF 0.0597% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0582%
Overall 0.0499% 806/1,613,912 alleles · ultra-rare
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.0636% 1,573
Remaining individualsnot grpmax-eligible 0.0368% 2,717
Admixed American 0.0333% 3,000
African / African-American 0.00933% 10,720
Finnishnot grpmax-eligible 0.00781% 12,804
South Asian 0.0011% 91,066

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
A2M
Protein
p.Val120=
Coding
c.360G>A
MANE Select
NM_000014
dbSNP
rs201901298
Type
single nucleotide variant
Location
chr12:9112447 (GRCh38)
Gene constraint
LOEUF 0.765 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.61 · 13 PDB
Full A2M gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/a2m-p-val120 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown